BALAMINES Overzicht aandelen
Balaji Amines Limited houdt zich bezig met de productie en verkoop van methylamines, ethylamines en derivaten van speciale chemicaliën en farmaceutische excipiënten in India.
Sneeuwvlok Score | |
---|---|
Waardering | 1/6 |
Toekomstige groei | 4/6 |
Prestaties in het verleden | 3/6 |
Financiële gezondheid | 6/6 |
Dividenden | 4/6 |
Balaji Amines Limited Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | ₹2,133.70 |
52 Week Hoogtepunt | ₹2,735.00 |
52 Week Laag | ₹1,960.00 |
Bèta | 1.15 |
11 maand verandering | -1.45% |
3 maanden verandering | -3.99% |
1 Jaar Verandering | 3.35% |
33 jaar verandering | -33.48% |
5 jaar verandering | 492.86% |
Verandering sinds IPO | 7,407.75% |
Recent nieuws en updates
Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Oct 23The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%
Aug 13Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 11At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?
Jul 30Recent updates
Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Oct 23The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%
Aug 13Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 11At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?
Jul 30Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00
Jun 20Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance Sheet
Jun 12There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Apr 05Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) Forecasts
Feb 15Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To Be
Nov 24Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?
Jul 14Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)
Jun 22Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?
Apr 05Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On Capital
Mar 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under Threat
Feb 15With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting Case
Feb 08Balaji Amines (NSE:BALAMINES) Seems To Use Debt Quite Sensibly
Dec 25Why The 42% Return On Capital At Balaji Amines (NSE:BALAMINES) Should Have Your Attention
Dec 02Should You Think About Buying Balaji Amines Limited (NSE:BALAMINES) Now?
Oct 14Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Sep 27Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jul 13Is There Now An Opportunity In Balaji Amines Limited (NSE:BALAMINES)?
Jun 16The Trend Of High Returns At Balaji Amines (NSE:BALAMINES) Has Us Very Interested
May 06Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Apr 12We Think Balaji Amines (NSE:BALAMINES) Can Stay On Top Of Its Debt
Mar 28Should You Investigate Balaji Amines Limited (NSE:BALAMINES) At ₹2,901?
Mar 14Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?
Sep 28Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Aug 23Is It Too Late To Consider Buying Balaji Amines Limited (NSE:BALAMINES)?
Jul 28Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jun 25Here's Why I Think Balaji Amines (NSE:BALAMINES) Is An Interesting Stock
May 22Rendement voor aandeelhouders
BALAMINES | IN Chemicals | IN Markt | |
---|---|---|---|
7D | 0.4% | 1.7% | 0.2% |
1Y | 3.4% | 21.5% | 35.3% |
Rendement versus industrie: BALAMINES presteerde slechter dan de Indian Chemicals -sector, die het afgelopen jaar een rendement van 21.5 % opleverde.
Rendement versus markt: BALAMINES presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van 35.3 % opleverde.
Prijsvolatiliteit
BALAMINES volatility | |
---|---|
BALAMINES Average Weekly Movement | 4.2% |
Chemicals Industry Average Movement | 5.7% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.3% |
10% least volatile stocks in IN Market | 4.0% |
Stabiele aandelenkoers: BALAMINES heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van BALAMINES is het afgelopen jaar stabiel geweest.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1988 | 1,084 | Dundurapu Reddy | www.balajiamines.com |
Balaji Amines Limited houdt zich bezig met de productie en verkoop van methylamines, ethylamines en derivaten van speciale chemicaliën en farmaceutische hulpstoffen in India. Het bedrijf is actief in twee segmenten, Chemicals en Hotel. Het biedt monomethylamine, dimethylamine, trimethylamine, monoethylamine, diëthylamine, triëthylamine en dimethyl- en diëthylamino-ethanol; en speciale chemicaliën, waaronder N-methylpyrrolidon, morfoline, 2-pyrrolidon, N-ethyl-2-pyrrolidon, gamma-butyrolacton, dimethylformamide, acetonitril, dimethylcarbonaat, propyleenglycol en propyleenkoolstofcarbonaat.
Balaji Amines Limited Samenvatting
BALAMINES fundamentele statistieken | |
---|---|
Marktkapitalisatie | ₹68.36b |
Inkomsten(TTM) | ₹1.95b |
Inkomsten(TTM) | ₹15.63b |
35.4x
Koers/Winstverhouding4.4x
P/S-verhoudingIs BALAMINES overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
BALAMINES resultatenrekening (TTM) | |
---|---|
Inkomsten | ₹15.63b |
Kosten van inkomsten | ₹8.75b |
Brutowinst | ₹6.87b |
Overige uitgaven | ₹4.92b |
Inkomsten | ₹1.95b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | 60.31 |
Brutomarge | 43.97% |
Nettowinstmarge | 12.51% |
Schuld/Eigen Vermogen Verhouding | 1.0% |
Hoe presteerde BALAMINES op de lange termijn?
Bekijk historische prestaties en vergelijking